Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 18Terminated 3Withdrawn 1Unknown 1Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 15Gastrointestinal 7Tumor-Agnostic 4Gynecologic 2Thoracic 1Breast 1

Conditions

Breast Neoplasms 544Triple Negative Breast Neoplasms 87Neoplasms 19Colorectal Neoplasms 19Lung Neoplasms 16Advanced Breast Cancer 16Neoplasm Metastasis 15Carcinoma, Non-Small-Cell Lung 15Prostatic Neoplasms 14Motor Activity 12Breast Cancer Lymphedema 12HER2-positive Breast Cancer 11Uterine Cervical Neoplasms 10Stomach Neoplasms 10Ovarian Neoplasms 10Carcinoma, Intraductal, Noninfiltrating 10Anxiety Disorders 10Endometrial Neoplasms 9Depression 8Brain Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Pain, Postoperative 6Pain 6Melanoma 6Lymphedema 6Head and Neck Neoplasms 6Colonic Neoplasms 6Cardiotoxicity 6Sarcoma 5Pancreatic Neoplasms 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Adenocarcinoma × Breast × Clear all
NCT07117214 2025-08-12

A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers

Novartis

Phase 1 Not yet recruiting
36 enrolled
BreastThoracic

Adenocarcinoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡